Dellora Investments Reports 2.3% Stake in Tenax Therapeutics, Inc. (TENX)

Dellora Investments LP, along with Dellora Investments Master Fund LP and Kevin Pyun, filed a Schedule 13G/A on May 15, 2026, regarding their holdings in Tenax Therapeutics, Inc. (TENX). As of the event date of March 31, 2026, Dellora Investments LP reported beneficial ownership of 394,665 shares of common stock, representing a 2.3% stake in the company. This reflects an increase from a previously reported 0.0% position. Specifically, Dellora Investments Master Fund LP holds 345,257 shares (2.0%), while Dellora Investments LP and Kevin Pyun are deemed to beneficially own the total 394,665 shares through their roles as investment adviser and principal, respectively. The filing indicates that the shares were acquired in the ordinary course of business and not for the purpose of changing or influencing the control of the issuer. Because the total ownership remains below the 5% threshold, the filing serves as an amendment to reflect current holdings rather than a major stakeholder notification.